Information Provided By: 
Fly News Breaks for September 7, 2017
GMED
Sep 7, 2017 | 07:44 EDT
BTIG analyst Ryan Zimmerman started coverage of Globus with a $37 price target and a Buy rating. The analyst says that the company has largely resolved the issues that had plagued its sales force, while its "best-in-class profitability profile has remained strong." Zimmerman says that the recent drop in the stock has created a buying opportunity, and he thinks it has multiple positive catalysts, including "rapid new product introductions, favorable 2H17 comps, improving market dynamics in spine, and the best EBITDA margins in spine."
News For GMED From the Last 2 Days
There are no results for your query GMED
